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Mammalian  cell  lines  are  characterized  by a complex  and  ﬂexible  metabolism.  A  single model  that  could
describe  the  variations  in metabolic  behavior  triggered  by  variations  in the  culture  conditions  would
be  a precious  tool in  bioprocess  development.  In this  paper,  we  introduce  an  approach  to  generate  a
poly-pathway  model  and use  it to  simulate  diverse  metabolic  states  triggered  in response  to removal,
reduction  or doubling  of amino  acids  in  the  culture  medium  of  an  antibody-producing  CHO  cell  line.
Macro-reactions  were  obtained  from  a metabolic  network  via  elementary  ﬂux mode  enumeration  andodeling
etabolic ﬂux analysis
lementary ﬂux modes
hinese hamster ovary cells
mino acid metabolism
oly-pathway model
the ﬂuxes  were  modeled  by kinetic  equations  with  saturation  and  inhibition  effects  from  external  medium
components.  Importantly,  one  set  of  kinetic  parameters  was  estimated  using  experimental  data  of  the
multiple  metabolic  states.  A  good  ﬁt  between  the model  and  the data  was obtained  for  the majority  of  the
metabolites  and the  experimentally  observed  ﬂux  variations.  We  ﬁnd  that  the  poly-pathway  modeling
approach  is promising  for the simulation  of  multiple  metabolic  states.
© 2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
A high demand for the complex biopharmaceuticals produced
n mammalian cells continues to stimulate improvement of cell
ines and bioprocess conditions. Since the nutritional requirements
or optimal growth and productivity vary between production cell
ines, the selection of cell culture media and feeds can greatly
ffect the process performances. The optimization of medium
nd feed formulations can be a time-consuming and complex
ask, as it involves balancing the concentrations of numerous,
otentially interacting, components (Bibila and Robinson, 2000;
urgener et al., 2006). Systematic screening combined with sta-
istical modeling can reduce the development time and costs.
nfortunately, a systematic approach based on the knowledge of
he cell metabolism is usually not included in these models.
∗ Corresponding author.
E-mail address: chotteau@kth.se (V. Chotteau).
ttp://dx.doi.org/10.1016/j.jbiotec.2016.03.015
168-1656/© 2016 The Authors. Published by Elsevier B.V. This is an open access article
.0/).A better understanding of the metabolic behavior and nutri-
tional requirements of mammalian cell lines can be achieved by
the analysis of the metabolite uptake and secretion rates (Xie and
Wang, 1994), preferably in combination with metabolic reaction
networks and metabolic ﬂux analysis (MFA) (Xie and Wang, 1996;
Altamirano et al., 2001, 2006; Sidorenko et al., 2008; Quek et al.,
2010; Xing et al., 2011; Ahn and Antoniewicz, 2012; Selvarasu et al.,
2012). Furthermore, the possible variations in metabolic behavior
has been examined and explained in models of bacterial, yeast and
mammalian cells by combining metabolic network analysis with
statistical methods such as principal component analysis (Sariyar
et al., 2006; Barrett et al., 2009; González-Martínez et al., 2014) and
regression techniques (Van Dien et al., 2006; Ferreira et al., 2011).
Kinetic models enable dynamic simulations and potential pre-
dictions of the cell culture in response to changes in external
conditions, e.g. in the medium composition. Such mechanistic
models could provide precious tools for bioprocess optimization.
However, modeling the complex and ﬂexible metabolism of mam-
malian cells is a challenging task for which the strategy will
depend on the aim and scope of the model. It involves deﬁning
 under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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 set of relevant metabolic reactions or pathways, the associated
inetic equations, and the model parameters which can be esti-
ated from literature and/or by ﬁtting to experimental data. The
ntracellular ﬂuxes in detailed networks can be estimated by e.g.
sotopic tracer-based analyses. Such techniques have provided use-
ul insights about the cell metabolism (Zupke and Stephanopoulos,
995; Goudar et al., 2010; Ahn and Antoniewicz, 2011; Sengupta
t al., 2011), however they are expensive (Zamorano et al., 2010),
nd challenging from experimental and computational point of
iews (Quek et al., 2010). Consequently, most kinetic models are
ased on simpliﬁed networks for which extracellular metabolite
nd viable cell concentration measurements, attainable by analyti-
al techniques commonly available in laboratories, are used to carry
ut the ﬂux calculations.
Several kinetic models of CHO cells have modeled intracellular
uxes by deﬁning one kinetic equation for each reaction in which
ntracellular metabolite concentrations are typically included (e.g.
sing convenience rate laws (Liebermeister and Klipp, 2006; Nolan
nd Lee, 2011; Ghorbaniaghdam et al., 2014; Robitaille et al., 2015)).
n contrast, the present study considers the pathway-based mod-
ling approach at macroscopic level, in which macro-reactions
epresent metabolic pathways that link the extracellular substrates
o products via the reactions of intracellular metabolism (see e.g.,
rovost, 2004). Thus, different pathways using the same reaction
an occur in parallel and are modeled separately, e.g. by generalized
onod- or Michaelis–Menten-type equations including only extra-
ellular metabolite concentrations (Provost, 2004; Provost et al.,
005; Gao et al., 2007; Dorka et al., 2009; Naderi et al., 2011;
amorano et al., 2013).
The set of possible macro-reactions of a metabolic network can
e obtained using pathway analysis tools, e.g., extreme pathways
EPs) or elementary ﬂux modes (EFMs) (Schuster and Hilgetag,
994; Klamt and Stelling, 2003; Papin et al., 2004; Llaneras and
icó, 2010). Both EPs and EFMs are formed by linear combinations
f reactions under the assumption of pseudo-steady state, and the
et of possible EPs is either identical to or constitutes a subset of
he possible EFMs of the same network. However, since EPs can
otentially miss important and physiologically meaningful path-
ays, EFMs have been considered more suitable for applications
uch as ﬁnding optimal pathways and the study of network ﬂexibil-
ty (Klamt and Stelling, 2003). Indeed, most pathway-based kinetic
odels of hybridoma and CHO cells were based on EFMs rather than
Ps (Provost, 2004; Provost et al., 2005; Gao et al., 2007; Dorka et al.,
009; Naderi et al., 2011; Zamorano et al., 2013).
Kinetic models of cell culture processes are often limited to
ertain prerequisites, e.g., carried out in a certain medium while
one or few of the metabolites are depleted. The scenario of amino
cid omission and/or depletion is relevant in cell culture (Wahrheit
t al., 2014), however rarely accommodated in the kinetic models.
urthermore, diverse metabolic behaviors have been described by
ultiple models (Nolan and Lee, 2011) in which each scenario is
odeled by a distinct set of reactions and/or parameters (Gao et al.,
007; Ghorbaniaghdam et al., 2014) and for which dynamic simula-
ions can be achieved via switching functions (Provost et al., 2005;
amorano et al., 2013).
The aim of the present work was to develop an approach to
apture multiple metabolic states in one single kinetic model.
he resulting study is a proof-of-concept focused on metabolic
tates obtained by varying the amino acid availability in the cul-
ure medium for a monoclonal antibody (mAb) producing CHO cell
ine. The model, named poly-pathway model, uses macro-reactions
i.e. the EFMs of a metabolic network) and kinetic equations with
ne set of parameters to capture the variations in growth rate and
etabolite uptake/secretion rates triggered in pseudo-perfusion
ultures when selected amino acids have been omitted, reduced
r doubled in the medium.hnology 228 (2016) 37–49
2. Materials and methods
2.1. Cell line and media
A CHO-K1 cell line producing IgG monoclonal antibody product
(mAb) was kindly provided by Selexis (Switzerland) and main-
tained in HyClone IC3TS SFM4CHOTM medium (Thermo Scientiﬁc).
Two proprietary and chemically-deﬁned media were kindly pro-
vided by Irvine Scientiﬁc (USA): IS-C and IS-0. The compositions of
IS-C and IS-0 were identical except that IS-0 was  obtained without
sodium bicarbonate and amino acids, and a lower concentration of
NaCl.
2.2. Cell culture maintenance, adaptation and expansion
Cell cultures were performed at 37 ◦C and 5% CO2 in Minitron
Incubators (INFORS HT, Switzerland). Cryopreserved CHO-K1 cells
were thawed into medium supplemented with 8 mM l-glutamine
(Irvine Scientiﬁc). The cells were routinely passaged in 125 mL
shake ﬂasks (Corning, USA) every 3–4 days to maintain them in
exponential growth phase. For the experiments, they were weaned
to IS-C medium over ﬁve passages and expanded in two  500 mL
shake ﬂasks during 4 days.
2.3. Preparation of media with varied concentrations of single
amino acids
Stock solutions of amino acids (Sigma–Aldrich), except glu-
tamine, were prepared in pure water or 1 M HCl. Concentrated
IS-0 was prepared in pure water and supplemented with sodium
bicarbonate (Fisher), sterile ﬁltered (0.2 m)  and aliquoted. The
amino acid stock solutions were added to create sixteen media with
varied concentration of amino acids (Table 1), including a control
(Ctrl) with amino acid balance as in IS-C. The pH, osmolality and
ﬁnal volume of each medium were adjusted before sterile ﬁltration
(0.2 m).  All the media were supplemented with 8 mM l-glutamine
with the exception of Q0 supplemented with water to compensate
for the dilution.
2.4. Pseudo-perfusion culture
Suspensions from the two expansion shake ﬂasks were pooled
and the cells were harvested by centrifugation at 1000 rpm (equiv-
alent to 180 g) for 5 min  (Jouan BR4i centrifuge, VWR  International).
The cells were seeded in sixteen 50 mL  TubeSpin bioreactors (TPP,
USA), one bioreactor for each medium, at 2 MVC/mL (MVC = 106
viable cells) and 12 mL  working volume. The bioreactors were agi-
tated at 200 rpm. During the following 10 days, the cells were
cultured in pseudo-perfusion mode to mimic  steady-state condi-
tions. The medium in each bioreactor was completely renewed on
a daily basis by centrifugation of an appropriate volume of cell sus-
pension followed by re-seeding of the cell pellet at 2 MVC/mL and
10 mL  working volume.
2.5. Analytical methods
Samples from the pseudo-perfusion cultures were collected
before and after each medium renewal and analyzed for viable
cell concentration, viability, and concentrations of glutamine, glu-
tamate, glucose, lactate and ammonium (NH4+) using a BioProﬁle
analyzer (Nova Biomedical, USA). Sample supernatants were stored
at −20 ◦C for subsequent analyses. The amino acid concentrations
were analyzed by reversed-phase high-performance liquid chro-
matography (HPLC) using Waters HPLC 2695 system with Waters
AccQTag column (Nova-PakTM 4 m C-18 column). Prior to the
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Table  1
Media used in pseudo-perfusion culture. The media #1–15 are referred to by code speciﬁed by the one-letter abbreviation of the varied amino acid and its concentration
level  in percent relative to the concentration in #16 (Ctrl).
# Amino acid Level (%) Code # Amino acid Level (%) Code
1 Alanine 0 A0 9 Glutamate 0 E0
2  Alanine 200 A200 10 Glycine 0 G0
3  Asparagine 0 N0 11 Threonine 200 T200
4  Asparagine 200 N200 12 Serine 0 S0
5  Aspartate 0 D0 13 Serine 200 S200
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v6  Aspartate 200 D200 
7  Glutamine 0 Q0 
8  Glutamine 200 Q200 
nalysis, sample supernatants were treated by protein precipita-
ion (trichloroacetic acid) and the AccQ Tag Reagent Kit (Waters,
SA). IgG concentrations were analyzed by HPLC (Waters HPLC
695, Protein A column POROS 20 micron Protein A ID Car-
ridge, Life Technologies), using a standard of human serum IgG
Sigma–Aldrich).
.6. Cell-speciﬁc rates
The cell-speciﬁc growth rate  and the cell-speciﬁc rates qext
or uptake or secretion of extracellular metabolites were calculated
ccording to
 =
ln
(
Xv
Xv,0
)
t − t0
, (1)
ext =  · c − c0
Xv − Xv,0
, (2)
here Xv,0 is the viable cell concentration after a medium renewal
nd Xv is the viable cell concentration before the following medium
enewal, c0 and c are the corresponding metabolite concentrations,
nd t0 and t are the corresponding consecutive time points of sam-
le collection.
. Theory
The goal of MFA  is to characterize the ﬂux vector v consis-
ent with: (i) the stoichiometry and irreversibility constraints of a
etabolic network; (ii) the experimentally determined uptake and
ecretion rates in qext; and (iii) the pseudo steady-state assumption
Quek et al., 2010), such that,
Aext
Aint
]
v =
[
qext
0
]
, vj ≥ 0, j ∈ Jirrev, (3)
here the metabolic network is deﬁned by the two  stoichiomet-
ic matrices Aext (rows of extracellular metabolites) and Aint (rows
f intracellular metabolites), and Jirrev is the set of irreversible
eactions. The whole set of EFMs of a metabolic network can be
numerated using computer software (in the present study, Meta-
ool (von Kamp and Schuster, 2006) in Matlab R2014b was used).
ach EFM is represented by a column vector el , and the whole set
s gathered in matrix E = [ e1 e2 . . . eL ]. Non-zero entries ej,l
n el indicate the involvement and stoichiometric contribution of
eaction j in EFM l. By deﬁnition, the EFMs are in the nullspace of
int , i.e.,
intE = 0. (4)
ach EFM is associated with a macroscopic ﬂux wl , and the set
Tf ﬂuxes are gathered in column vector w = [w1 w2 . . . wL ] .
urthermore, the reaction ﬂuxes in v can be expressed using the
FMs and the macroscopic ﬂuxes,
 = Ew. (5)14 Proline 200 P200
15 Cysteine 50 C50
16 – – Ctrl
A macroscopic representation is obtained by combining the exter-
nal part of (3) with (5),
qext
(3)
↓
= Aextv
(5)
↓
= AextEw = Amacw, (6)
where Amac is generated via multiplication of Aext and E. Finally,
internal metabolites are eliminated as steady state is satisﬁed by
the EFMs,
0
(3)
↓
= Aintv
(5)
↓
= AintEw
(4)
↓
= 0. (7)
4. Results and discussion
Our long-term goal is to provide models of the cell metabolism
as simulation or prediction tools. Modeling of a single metabolic
state can provide a better understanding of the metabolism under
a given set of conditions, however, such models are speciﬁc and
likely not valid for other states. The proposed poly-pathway model
is based on the fact that the cells have a complex and ﬂexible
metabolism in which metabolic pathways are used in different
combinations in response to extracellular stimuli, and are able to
switch the metabolic pathways used e.g. to compensate for nutrient
depletion. To serve as a fully useful prediction tool, a model should
be able to simulate the possible pathways available to the cells and
render these in response to varying extracellular conditions. More-
over, we  set out to develop a single model, i.e. one set of equations
with deﬁned parameters. We  postulated that the creation of such
a model is possible if (i) the model structure can support a ﬂexible
modeling frame, and (ii) sufﬁciently rich information generated in
experiments is used for the model identiﬁcation.
In the proposed poly-pathway model, the ﬂexibility and com-
plexity of the cell metabolism is reﬂected in a ﬂexible model
structure. First, multiple metabolic pathways are represented by
macro-reactions derived from the EFMs of a highly reversible
metabolic network. Second, alternative kinetic scenarios are
deﬁned including, e.g., substrate saturation, product inhibition
and activation of pathways in response to omission/depletion of
amino acids. Furthermore, rich information generated in experi-
ments, ideally from a large number of metabolic states, i.e. different
responses to various stimuli provoking different metabolic states,
is used for the model identiﬁcation. Based on this information the
pathways, which are active in a reference metabolic state and in
different states obtained by various external stimuli, are identiﬁed.
To generate the experimental data set, a system in perfusion
mode with maintained cell density is used. In this manner, the
effects from transient states encountered in e.g. batch and fed-
batch cultures are avoided and the responses are related to the
applied stimuli only. Ideally, information should be collected from
a large number of metabolic states, why  pseudo-perfusion systems
are adopted instead of perfusion ones to increase the throughput.
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Fig. 1. Example of pseudo-perfusion concentration data in G0. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of
the  article.)
Fig. 2. Metabolic states in pseudo-perfusion culture caused by varied initial medium concentration of single amino acids. Bars represent the percentage of average ﬂux with
respect to the control (Ctrl). Bars for which the ﬂux differ notably from the control are highlighted in red (decreased ﬂux), green (increased ﬂux), blue (shifted direction).
Error  bars represent the standard deviation of 4–7 culture days. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web  version
of  the article.)
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Fig. 3. Metabolic network map  for CHO cell metabolism. Orange: external pools. Blue: internal amino acid pools. Green indicate essential amino acid catabolism (not included
in  the model). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web  version of the article.)
Table 2
Metabolic network reactions for CHO cell metabolism: reactions v1–v30; →:  irreversible; ↔:  reversible; ext: external metabolite. Glc: glucose; Lac: lactate; 3PG: 3-
phosphoglycerate; Pyr: pyruvate; AcCoA: acetyl-CoA; Oxal: oxaloacetate; aKG: alfa-ketoglutarate; SucCoA: succinyl-CoA; Suc: succinate; Mal: malate; standard abbreviations
for  amino acids.
Glycolysis Biomass synthesis
v1 1 Glcext → 2 3PG v23 0.033 Glcext + 0.002 Cysext + 0.006 Ileext
v2 1 3PG → 1 Pyr +0.012 Leuext + 0.013 Lysext + 0.003 Metext
v3 1 Pyr → 1 Lacext +0.005 Pheext + 0.007 Proext + 0.007 Thrext
+0.001 Trpext + 0.003 Tyrext + 0.008 Valext
TCA-cycle +0.011 Alaext + 0.007 Asnext
v4 1 Pyr → 1 AcCoA + CO2,ext +0.020 Aspext + 0.025 Glnext + 0.007 Gluext
v5 1 AcCoA + 1 Oxal → 1 aKG + CO2,ext +0.014 Glyext + 0.009 Serext → 1 Biomassext
v6 1 aKG → 1 SucCoA + CO2,ext
v7 1 SucCoA ↔ 1 Suc Transport
v8 1 Suc ↔ 1 Mal  v24 1 Ala ↔ 1 Alaext
v9 1 Mal  ↔ 1 Oxal v25 1 Asnext ↔ 1 Asn
Anaplerosis v26 1 Asp ↔ 1 Aspext
v10 1 Mal  ↔ 1 Pyr + CO2,ext v27 1 Glnext ↔ 1 Gln
v28 1 Glu ↔ 1 Gluext
Amino acid metabolism v29 1 Glyext ↔ 1 Gly
v11 1 aKG + 1 Asp ↔ 1 Oxal + 1 Glu v30 1 Serext ↔ 1 Ser
v12 1 aKG + 1 Ala ↔ 1 Pyr + 1 Glu
v13 1 Gln ↔ 1 NH4,ext + 1 Glu
v14 1 Glu ↔ 1 NH4,ext + 1 aKG
v15 1 Proext → 1 Glu
v16 1 Cysext → 1 NH4,ext + 1 Pyr
v17 1 Ser → 1 NH4,ext + 1 Pyr
v18 1 Gly ↔ 1 NH4,ext + CO2,ext
v19 1 Asn → 1 NH4,ext + 1 Asp
4
t
s
t
m
a
p
wv20 1 Asp + 1 Gln ↔ 1 Asn + 1 Glu
v21 1 3PG + 1 Glu → 1 aKG + 1 Ser
v22 1 Ser ↔ 1 Gly
.1. Effect of amino acid availability on metabolic behavior
Ten amino acids (alanine, asparagine, aspartate, glutamine, glu-
amate, glycine, serine, threonine, cysteine, and proline) were
elected after being identiﬁed as potential medium optimization
argets in a comparison of amino acid ratios in the experimental
edium IS-C and other CHO culture media. Several of these amino
cids had also been observed to inﬂuence the cell metabolism in
reliminary experiments in our lab. Based on IS-C, ﬁfteen media
ere created in which individual amino acids were removed (A0,N0, D0, Q0, E0, G0 and S0), reduced at 50% (C50) or doubled in con-
centration (A200, N200, D200, Q200, T200, S200 and P200). When
the anabolism of a given amino acid existed in CHO cells, its omis-
sion was favored over its reduction to provoke the use of different
metabolic pathways. The omission of an amino acid would trigger
pathway(s) alternative to those used with the original medium.
A reduction, which would provoke the amino acid depletion dur-
ing an experiment, was systematically avoided. It was anticipated
that glutamine removal (Q0) would likely reduce the cell growth,
however glutamine synthesis should be possible via activity of
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Table 3
Choice of kinetic equations. With starting point in the general kinetic equation (8), one or several alternative kinetic equations were deﬁned for each macro-reaction. S
(or  S1 + S2 + · · · + Ss) are substrates and P (or P1 + P2 + · · · + Pp) are products of the macroscopic reaction, respectively. X represents an amino acid which was omitted in the
experiments. EAAs are the essential amino acids. ↓ indicates dependence on substrate availability with potential saturation effect. ⊥ indicates inhibition (or activation at
reduction/omission) by a product/metabolite.
1a S
EAAs Gln
↓ ↓
−→ Biomass 1b S
EAAs Gln
↓ ⊥
−→ Biomass
The  macro-reaction representing biomass synthesis was duplicated and modeled by two alternative equations. Both depend on
availability of EAAs. The ﬁrst one depends on glutamine availability (1a) and the second one is activated by glutamine omission (1b).
2  S
S
↓
→P
For the other macro-reactions in the initial set, the ﬂuxes depend on substrate availability and saturation only.
3a  S
S X
↓ ⊥
−→ X  + P2 +
·  · · + Pp
3b S → X
S X
↓ ⊥
−→ P
Macro-reactions producing an amino acid that was omitted in the experiments were duplicated. Their ﬂuxes were modeled like in (2)
and  with product inhibition from the omitted amino acid (3a). Macro-reactions with internal production and consumption of an
amino acid that was omitted in the experiments were duplicated. Their ﬂuxes were modeled like in (2) and with inhibition from the
omitted amino acid (3b). Both 3a and 3b allow activation of alternative pathways in response to omission of amino acids.
4a  S
S Asn
↓ ⊥
−→ Asp +
P2 + · · · + Pp
4b Asp + S2 + · · · +
Ss
S Asn
↓ ↓
−→ P
Macro-reactions producing aspartate were duplicated and their ﬂuxes modeled like in (2) and with inhibition from asparagine (4a).
Macro-reactions consuming aspartate were duplicated and their ﬂuxes modeled like in (2) and with inhibition from asparagine (4b).
5a  S
S Gln
↓ ⊥
−→ Glu +
P2 + · · · + Pp
5b Glu + S2 + · · · +
Ss
S Gln
↓ ↓
−→ P
Macro-reactions producing glutamate were duplicated and their ﬂuxes modeled like in (2) and with inhibition from glutamine (5a).
Macro-reactions consuming glutamate were duplicated and their ﬂuxes modeled like in (2) and with inhibition from glutamine (5b).
6  Asn + S2 + · · · +
Ss
S2, . . ., Ss Asn
↓ ⊥−→ P
Macro-reactions consuming asparagine were duplicated and their ﬂuxes modeled like in (2) however the dependence on asparagine
availability was  replaced by inhibition from asparagine.
7 S
S Asn
↓ ⊥
−→ Ala +
P2 + · · · + Pp
Macro-reactions producing alanine were duplicated and their ﬂuxes modeled like in (2) with inhibition from asparagine.
8a  S
S Cys
↓ ⊥
−→ Ala +
P2 + · · · + Pp
8b S
S Cys
↓ ⊥
−→  Ser +
P2 + · · · + Pp
8a Macro-reactions producing alanine were duplicated and their ﬂuxes modeled like in (2) and with inhibition from cysteine (8a).
Macro-reactions producing serine were duplicated and their ﬂuxes modeled like in (2) with inhibition from cysteine (8b).
9  Glc
S Gln
↓ ⊥
−→ Lac
 lacta
g
c
c
r
t
(
n
t
t
c
m
4Macro-reactions consuming glucose and producing
and  with activation at glutamine omission.
lutamine synthetase (Sanders and Wilson, 1984). While cysteine
an be synthesized from methionine, the cysteine and methionine
oncentrations in IS-C were comparatively low and cysteine was
educed to 50% to avoid its depletion and potential growth limi-
ation. Proline cannot be synthesized in the present CHO cell line
Selexis, personal communication).
Except for amino acids deliberately omitted in the media,
one of the measured metabolites were depleted during the cul-
ures – depletion would imply incorrect ﬂux measurements since
hose are calculated from daily sampling analyses. Examples of
oncentration proﬁles are shown in Fig. 1. For a majority of
etabolites and media the metabolic rates were stable from day
 and on, and data from this culture period were consideredte as their only substrate and product, respectively, were modeled like in (2)
for modeling. Apparent outliers were removed, resulting in a
data set consisting of 4–7 experimental rates per metabolite and
medium.
The viable cell concentration increased between each medium
renewal while the viability remained high (>94%) in 14 of 16
media, indicating that the cells remained in exponential growth
phase. In Ctrl, the speciﬁc growth rate was  0.60 ± 0.31/day. The
cysteine reduction in C50 caused a reduction in viability, which
however remained >87%, while the growth was similar to the other
media. In Q0, the viable cell density initially decreased between
medium renewals, accompanied by a drop in viability (Fig. S1).
The growth and metabolism in Q0 appeared to have stabilized by
day 7. However, the initial viable cell concentration (0.6 × 106/mL),
E. Hagrot et al. / Journal of Biotechnology 228 (2016) 37–49 43
Fig. 4. Simulated (purple line) and experimental rates (blue circle) in pmol/cell, day for biomass and metabolites glucose (Glc), lactate (Lac), glutamine (Gln), ammonium
(NH4+), and alanine (Ala). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web  version of the article.)
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reaction linking one or several external substrates to one or several
external products (Table S6) by calculation of Amac using (6). In ourrowth rate (0.16 ± 0.08/day) and viability (64±2%) were notably
educed.
The metabolic state associated with each medium was  char-
cterized by the growth rate, speciﬁc mAb  production rate
nd metabolite uptake/secretion rates. A comparison of selected
etabolic rates are illustrated in Fig. 2. Varied availability of
sparagine, aspartate, glutamine, glycine, serine or cysteine trig-
ered distinct metabolic behaviors as demonstrated by signiﬁcant
ifferences in the metabolic rates, while alterations of alanine, glu-
amate, proline and threonine had a smaller impact. In several cases
he rates of aspartate, glycine and serine were reversed, i.e. shifted
rom secretion to uptake or vice-versa.
.2. Model development
.2.1. Metabolic network
A metabolic network of CHO cell metabolism (Fig. 3) was
onstructed based on information available in the literature
Altamirano et al., 2001; Nelson and Cox, 2005; Zamorano et al.,
010) and KEGG Pathways database (Kanehisa and Goto, 2000;
anehisa et al., 2014). The network included 30 reaction ﬂuxes
v1–v30 in Table 2) representing glycolysis, TCA-cycle, amino
cid metabolism, biomass synthesis and transports between the
ell and the medium. The biomass synthesis was represented as
iomass being produced directly from external substrates (v23).The coefﬁcients were calculated by carbon and nitrogen balancing
(Table S2) as described in Gambhir et al. (2003) and using a dry
weight to cell conversion factor of 280 pg/cell (Berrios et al.,
2011) (Table S3). The network included 38 metabolites (Table
S1). Eight metabolites (3PG, AcCoA, aKG, SucCoA, Suc, Mal, Pyr,
and Oxal) belonged to internal pools only. 23 metabolites were
external of which 22 were experimentally measured and one
treated as unmeasured (CO2). To limit the number of EFMs in the
subsequent enumeration, only seven metabolites were included
in both external and internal pools and essential amino acid (EAA)
catabolism was  excluded. Eighteen of the ﬂuxes, including the
seven transport ﬂuxes, were deﬁned as reversible to allow the
generation of many different pathways.
4.2.2. Macroscopic reactions
Using the metabolic network deﬁned by reaction ﬂuxes v1–v30,
379 EFMs were obtained by EFM enumeration (for details see the
Supplementary material). Each EFM was translated into a macro-case, the macro-reactions of some of the EFMs were identical. Each
EFM in E represents a unique combination of reactions, however,
some of these combinations can give macro-reactions using the
same amount of substrates and products.
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Pro),  serine (Ser), and glycine (Gly). (For interpretation of the references to color in
.2.3. Kinetic equations
A general kinetic equation was formed as a starting point for
odeling of the macroscopic ﬂux (wl) over macro-reaction l:
l =  wmax,l ·
∏
i  ∈  Mext,s,l
Si
Ks,i,l
Si
Ks,i,l
+  1︸  ︷︷  ︸
substrate  saturation
·
∏
i  ∈  Mext,p,l
1
Pi
Kp,i,l
+  1︸  ︷︷  ︸
product  inhibition
·
∏
i  ∈  Mext,r,l
1
Ri
Kr,i,l
+  1︸  ︷︷  ︸
metabolite  inhibition
.  (8)
ext,s,l and Mext,p,l are the sets of external substrates and products
n macro-reaction l, respectively, while Mext,r,l is a set of external
etabolites free of choice. Si, Pi, Ri are the concentrations of exter-
al metabolites in Mext,s,l, Mext,p,l and Mext,r,l, respectively (i.e., the
nitial concentrations of medium components at each day of the
seudo-perfusion cultures). wmax,l is a constant parameter and rep-
esents the maximum ﬂux over macro-reaction l. Ks,i,l is a constant
aturation parameter for metabolite i in Mext,s,l, and Kp,i,l and Kr,i,l are
onstant inhibition parameters for metabolite i in Mext,p,l and Mext,r,l,
espectively. The actual macroscopic ﬂux wl can then depend on:
i) substrate availability and saturation; (ii) product inhibition; and
iii) inhibition from metabolites of choice. The inhibition in (ii) and
iii) means that the ﬂux over the macro-reaction decreases with
ncreasing initial concentration of the product or metabolite of
hoice. This can also be described as an activation of the pathway
n response to a reduction or omission of the product/metabolite.
In the ﬁnal model, the simulated ﬂuxes over the macro-reactions
ust balance the substrate demand for biomass synthesis as wells the observed rates of substrate uptake and by-product secretion
n each medium. For each macro-reaction, one or several alter-
ative kinetic equations were deﬁned as summarized in Table 3.
he choice of equations was made based on inspection of theetabolites glutamate (Glu), aspartate (Asp), asparagine (Asn), cysteine (Cys), proline
gure legend, the reader is referred to the web version of the article.)
experimental and simulated rates and reasoning concerning the
potential regulation of pathways in response to the variations in
amino acid availability. In the case of an additional kinetic equa-
tion was  deﬁned for a particular macro-reaction, the column for
this macro-reaction was  duplicated in Amac .
4.3. Poly-pathway approach
4.3.1. Parameter estimation
To reduce the number of parameters to be estimated from the
limited data set (Provost et al., 2005; Gao et al., 2007; Zamorano
et al., 2013), Ks,i,l, Kp,i,l, Kr,i,l were deﬁned prior to the model-
ﬁtting (Table S6). The values were chosen by considering the
initial concentrations of each component and its effect on the
metabolic behavior. Thereby, (8) was  pre-calculated. The wmax,l
were unknown parameters determined by:
Amacw
(8)
↓
= Bwmax = qext, (9)
where the matrix B is the combination of the pre-calculated parts
of (8) with Amac (details in the Supplementary information).
Index k was deﬁned for a system on the form (9) generated
from data of one medium and one culture day: Bkwmax = qext,k,
where k = [1, 2, . . .,  K] and K is the total number of culture days
for all the media. To obtain a single model, data from the parallel
pseudo-perfusion experiments were combined for the parameter
estimation by forming a stacked matrix B∗ and a stacked vector q∗ext,
B∗wmax = q∗ext, (10)
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Thr),  tryptophan (Trp), tyrosine (Tyr), methionine (Met) and valine (Val). (For inter
ersion of the article.)
here B∗ = [ BT1 BT2 . . . BTK ]
T
and q∗ext =
qText,1 q
T
ext,2 . . . q
T
ext,K ]
T
. Prior model-ﬁtting, system (10)
as normalized to account for the variation in order of magnitude
etween rates, generating q∗norm and B
∗
norm. Each row in (10) was
andled separately in the following way. In case |qext| > 10−2,
he row was divided by |qext|. In case |qext| ≤ 10−2, the row was
ivided by 1 to avoid numerical issues. wmax was estimated by
east-squares methodology using the function lsqlin (Matlab
2014b),
minimize
wmax
1
2
‖q∗norm − B∗normwmax‖22,
subject to wmax ≥ 0,
(11)
nd is presented in Table S6.
.3.2. Simulation accuracy
Using one single model, a simulation was performed based on
he initial component concentrations in the sixteen different media
nd one set of parameter values as input. Overall, the simulated
ates showed a good ﬁt with the experimental data (Figs. 4–6).
he model simulated growth in all the media, even when cer-
ain amino acids had been omitted (A0, N0, D0, Q0, E0, G0, and
0 in Fig. 4), including the reduced growth in Q0. For Q0, the
hifts toward increased glucose uptake and lactate secretion and
he absence of glutamine uptake in Q0 were captured. For the
ther media, the model simulated glutamine consumption. Thetabolites isoleucine (Ile), leucine (Leu), lysine (Lys), phenylalanine (Phe), threonine
ion of the references to color in this ﬁgure legend, the reader is referred to the web
secretion of the by-products ammonium and alanine were gen-
erally well simulated, including the increased alanine secretion
in N0 and Q200, and the reduced alanine secretion in Q0. An
increase in alanine secretion was simulated for C50, however,
the rate was  underestimated. The model captured the general
trend of glutamate secretion, except for the increased produc-
tion in Q0. Aspartate uptake/secretion was  in general satisfactorily
simulated except for a slight underestimation (A200, N200) and
overestimation (D0) of the secretion in certain media. Asparagine
uptake was  well-simulated, except that for N0 the model sim-
ulated asparagine secretion. Serine and glycine secretion/uptake
were generally well simulated. The serine secretion in C50 was
however slightly underestimated as was the glycine secretion in
S200.
Finally, the EAA uptake rates were generally underestimated by
the model (Fig. 6). This could indicate inaccuracies in the assumed
biomass composition and/or an active EAA catabolism (recall that
EAA catabolism was  not included in the network to limit network
complexity).
For each component, the simulation accuracy was  quantiﬁed by
the average absolute and relative error, which is available in the
Supplementary information (Table S8).4.4. Fluxes
Using the poly-pathway model, we calculated the average of
the ﬂux distribution (v) over the metabolic network for each
46 E. Hagrot et al. / Journal of Biotechnology 228 (2016) 37–49
Fig. 7. Flux maps for the control (Ctrl), asparagine omission (N0), asparagine doubling (N200), glutamine omission (Q0) and glutamine doubling (Q200). Arrows in black
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n  top of the black arrows. For ﬂuxes <0.3, the colored arrows were omitted wi
nterpretation of the references to color in this ﬁgure legend, the reader is referred 
edium (Table 4). We  also ranked the kinetic equations of the
acro-reactions according to decreasing wmax,l and calculated the
verage of the macroscopic ﬂux, (wl) for each medium (Table S7).
t should be noted that, since each macro-reaction is not neces-
arily unique, the calculated ﬂux distributions are not necessarily
nique and thus the characterization of the metabolic state given
y the model in each medium is plausible but it is not possible to
athematically prove that this is the only solution. The ﬂux dis-
ributions for the control (Ctrl) are illustrated in network maps
n Fig. 7. The largest inﬂuences of the amino acid depletions and
upplementations were in the cases of depletion of glutamine or
sparagine. These latter cases, taken in contrast with supplemen-
ation of these amino acids, are therefore described more in detailrrows in blue or orange with thickness proportional to the ﬂux were superimposed
eption for v11 which shifts direction and is represented by a dotted arrow. (For
 web  version of the article.)
here as illustration of the observed differences detected by the
model and their ﬂux distributions are given in Fig. 7. The other
amino acid depletions and supplementations had smaller inﬂu-
ences, with ﬂuxes maintained but intensities varied, as can be seen
in Table 4.
The following pathways were common for all the media: the
consumption of glucose (v1) which was  converted into pyruvate
directly via 3PG (v2) or via serine (v17 and v21 in combination with
v14); production of pyruvate from malate (v10) and from cysteine
degradation (v16); conversion of pyruvate into alanine (v12) and
lactate (v3), and into AcCoA for entry into the TCA-cycle (v4); the
net inﬂow of aKG into the TCA-cycle at v6 (except in Q0); conversion
of malate into oxaloacetate (v9); production of glutamate from aKG
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Table  4
Average ﬂuxes (pmol/cell, day) in each medium calculated using the poly-pathway model.
Flux Reaction A0 A200 N0 N200 D0 D200 Q0 Q200 E0 G0 T200 P200 S0 S200 C50 Ctrl
v1 Glcext → 2 3PG 3.13 3.18 3.56 3.29 3.20 3.17 9.24 2.86 3.48 3.18 3.18 3.17 3.20 3.19 3.22 3.20
v2 3PG → Pyr 1.15 1.16 1.00 1.25 1.16 1.16 1.61 1.13 1.15 1.15 1.15 1.15 1.15 1.15 1.17 1.16
v3 Pyr → Lacext 6.27 6.29 6.76 6.38 6.34 6.28 14.63 5.90 6.25 6.31 6.28 6.29 6.31 6.29 6.33 6.33
v4 Pyr → CO2ext + AcCoA 2.49 2.50 3.18 2.64 2.49 2.51 4.61 2.39 2.51 2.56 2.54 2.45 2.51 2.49 2.54 2.51
v5 AcCoA + Oxal → CO2ext + aKG 2.49 2.50 3.18 2.64 2.49 2.51 4.61 2.39 2.51 2.56 2.54 2.45 2.51 2.49 2.54 2.51
v6 aKG → CO2ext + SucCoA 3.33 3.31 4.55 3.39 3.34 3.26 4.57 3.45 3.28 3.33 3.35 3.30 3.33 3.31 3.37 3.29
v7 SucCoA ↔ Suc 3.33 3.31 4.55 3.39 3.34 3.26 4.57 3.45 3.28 3.33 3.35 3.30 3.33 3.31 3.37 3.29
v8 Suc ↔ Mal 3.33 3.31 4.55 3.39 3.34 3.26 4.57 3.45 3.28 3.33 3.35 3.30 3.33 3.31 3.37 3.29
v9 Mal  ↔ Oxal 2.54 2.53 3.46 2.51 2.57 2.53 4.50 2.48 2.56 2.63 2.60 2.51 2.55 2.54 2.56 2.55
v10 Mal  ↔ CO2ext + Pyr 0.79 0.77 1.09 0.88 0.77 0.72 0.07 0.97 0.72 0.70 0.75 0.79 0.78 0.77 0.81 0.74
v11 aKG + Asp ↔ Oxal + Glu −0.06 −0.03 −0.28 0.14 −0.08 −0.03 0.11 −0.09 −0.05 −0.07 −0.05 −0.06 −0.04 −0.05 −0.01 −0.04
v12 aKG + Ala ↔ Pyr + Glu −0.56 −0.51 −1.05 −0.60 −0.52 −0.48 −0.06 −0.61 −0.48 −0.51 −0.56 −0.51 −0.55 −0.52 −0.61 −0.49
v13 Gln ↔ NH4ext + Glu 0.58 0.57 0.65 0.65 0.60 0.55 −0.33 0.73 0.59 0.51 0.54 0.58 0.57 0.57 0.57 0.56
v14 Glu ↔ NH4ext + aKG −4.89 −4.93 −6.08 −5.06 −4.99 −4.94 −16.86 −4.23 −5.57 −5.01 −5.02 −4.91 −5.01 −4.97 −5.06 −5.00
v15 Proext → Glu 0.03 0.03 0.05 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.03 0.03
v16 Cysext → NH4ext + Pyr 0.05 0.05 0.11 0.06 0.08 0.05 0.02 0.06 0.06 0.05 0.05 0.05 0.05 0.05 0.04 0.06
v17 Ser → NH4ext + Pyr 7.32 7.31 8.79 7.43 7.35 7.33 17.60 6.73 7.31 7.48 7.43 7.27 7.39 7.32 7.46 7.37
v18 Gly ↔ CO2ext + NH4ext −2.36 −2.31 −2.86 −2.31 −2.28 −2.30 −0.75 −2.36 −1.70 −2.33 −2.28 −2.34 −2.29 −2.27 −2.35 −2.29
v19 Asn → NH4ext + Asp 0.66 0.65 1.02 0.72 0.66 0.63 0.42 0.76 0.67 0.64 0.65 0.64 0.65 0.65 0.66 0.64
v20 Asp + Gln ↔ Asn + Glu 0.54 0.52 1.14 0.39 0.51 0.51 0.30 0.67 0.55 0.54 0.54 0.54 0.52 0.53 0.52 0.51
v21 3PG + Glu → aKG + Ser 5.12 5.19 6.11 5.34 5.24 5.19 16.87 4.59 5.80 5.20 5.21 5.19 5.24 5.23 5.26 5.25
v22 Gly ↔ Ser 2.24 2.18 2.75 2.17 2.17 2.19 0.69 2.20 1.57 2.14 2.15 2.27 2.15 2.15 2.23 2.18
v23 Biomass synthesis 6.00 5.98 5.94 5.93 5.96 5.97 1.97 6.31 5.97 5.97 5.99 5.98 5.97 5.98 5.97 5.95
v24 Ala ↔ Alaext 0.56 0.51 1.05 0.60 0.52 0.48 0.06 0.61 0.48 0.51 0.56 0.51 0.55 0.52 0.61 0.49
v25 Asnext ↔ Asn 0.11 0.13 −0.12 0.33 0.14 0.12 0.12 0.09 0.12 0.10 0.11 0.10 0.12 0.12 0.14 0.12
v26 Asp ↔ Aspext 0.17 0.16 0.16 0.19 0.23 0.14 0.01 0.19 0.16 0.17 0.16 0.16 0.16 0.16 0.16 0.16
v27 Glnext ↔ Gln 1.12 1.09 1.79 1.04 1.12 1.06 −0.03 1.39 1.15 1.04 1.09 1.11 1.09 1.10 1.09 1.07
v28 Glu ↔ Gluext 0.31 0.32 0.47 0.34 0.30 0.33 0.04 0.36 0.42 0.30 0.32 0.30 0.30 0.32 0.29 0.32
v29 Glyext ↔ Gly −0.12 −0.12 −0.11 −0.14 −0.11 −0.12 −0.06 −0.15 −0.12 −0.19 −0.13 −0.07 −0.13 −0.12 −0.12 −0.11
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v14) and proline degradation (v15); degradation of asparagine into
spartate (v19); and asparagine synthesis (v20).
The asparagine availability inﬂuenced several ﬂuxes. In N0, the
sparagine synthesis was increased (v20) together with several of
he other ﬂuxes in, e.g., the TCA-cycle (as more pyruvate and aKG
ntered this cycle), the anaplerotic reaction forming pyruvate from
alate and in the amino acid metabolism. In N200, asparagine syn-
hesis v20 was decreased, while v11 shifted direction. Glutamine
vailability had great impact on the ﬂuxes. In Q0, the ﬂuxes from
lucose to pyruvate and for lactate formation were increased. More
yruvate entered the TCA-cycle while there was  an outﬂow of
KG, and the ﬂuxes over the anaplerotic reaction v10 and ala-
ine formation in v12 were greatly decreased. v11 shifted direction
oward glutamate production from aspartate. v14 which produces
lutamate from aKG was highly increased and v13 was  used for
lutamine synthesis. In Q200, the ﬂuxes from glucose to pyruvate
nd lactate were slightly decreased, while more aKG entered the
CA-cycle and the anaplerotic ﬂux v10 was increased. Several of the
uxes in the amino acid metabolism were also increased, e.g. the
sparagine synthesis and degradation, and the alanine formation
v12).
. Conclusion and perspectives
In the present study, we have presented an approach to sim-
late multiple metabolic states obtained in parallel cell cultures
y a poly-pathway model, with particular focus on the effects of
ariations in amino acid availability. The omission, reduction or
oubling of single amino acids provoked changes in growth and/or
etabolic uptake and secretion rates, indicating that regulation and
sage of alternative metabolic pathways had occurred. Using a sin-
le poly-pathway model, cell growth and metabolic rates could be
imulated including increased or reduced rates as well as the shifts
etween uptake and secretion, demonstrating the potential of our
pproach.0.04 −0.06 −0.06 0.14 0.07 −0.19 −0.00 −0.07 −0.04 −0.05
The present methodology relies on the enumeration of EFMs
of a metabolic network. The number of EFMs grows rapidly with
increasing network size and complexity and the enumeration
eventually becomes computationally prohibitive. In this work, the
network was simpliﬁed to reduce the number of EFMs, e.g. by
limiting the number of reactions and internal pools, and exclud-
ing EAA catabolism. Meanwhile, complex reaction networks could
provide a rich set of accurate and relevant metabolic pathways
for a poly-pathway model and potentially improve the simulation
accuracy. Indeed, several strategies to generate EFM subsets from
more complex networks have been proposed: e.g. computation
of the shortest pathways (de Figueiredo et al., 2009), subsys-
tem analysis (Kaleta et al., 2009), random sampling (Machado
et al., 2012; Tabe-Bordbar and Marashi, 2013), yield analysis (Song
and Ramkrishna, 2009), a maximum entropy assumption (Badsha
et al., 2014) or taking the experimental data set into considera-
tion (Jungers et al., 2011; Zamorano et al., 2013; Oddsdóttir et al.,
2015).
Some previous studies on EFM-based kinetic models sug-
gested general Michaelis–Menten-type equations with substrate
saturation as a starting point (Provost, 2004; Provost et al.,
2005; Gao et al., 2007; Zamorano et al., 2013). However, we
found that the diverse metabolic behaviors in the present
work required more complex kinetic equations, incorporating
also inhibition from products and other metabolites. In par-
ticular, inhibition allows the activation of certain pathways in
response to the omission of medium components. The resulting
kinetic equations have similarities with the equations applied for
reaction-based modeling of CHO cell metabolism (Nolan and Lee,
2011; Ghorbaniaghdam et al., 2014; Robitaille et al., 2015), for
which more complex and speciﬁc kinetic equations are usually
deﬁned, possibly even using external component concentrations
as inputs. Ferreira et al. combined EFMs and partial least-squares
regression to identify EFMs that explain the variation in ﬂux
data (Ferreira et al., 2011), an approach which could aid the
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dentiﬁcation of EFMs in need of kinetic design in a poly-pathway
odel.
Effects of variations in the amino acid availability are rele-
ant for applications such as medium or feed development. In the
resent study, using the information of the extracellular metabo-
ites only, the poly-pathway model provided a tool to identify which
etabolic pathways were used with the original culture medium
Ctrl). Furthermore, the model showed which variations in the
etabolic ﬂuxes occurred in response to amino acids omission or
urther supplementation. In the future, other amino acid compo-
itions and other types of stimuli could be explored, e.g., other
edium components, environmental parameters, or cell lines. We
elieve that the poly-pathway model approach can be applied to
ny reaction network-based model for any cell type, given that the
FMs can be generated and that the kinetics can be adequately
odeled.
Finally, we envision that the poly-pathway modeling concept
an be combined with other types of information and models such
s integrating measurements of intracellular metabolites or includ-
ng specialized pathways (e.g. glycosylation), for instance using a
odular approach.
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